Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bollinger Bottleneck Buy Pattern 1
Bollinger Bottleneck Buy Pattern 2
Bollinger Bottleneck Sell Pattern

Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.

Source: http://www.bollingerbands.com

RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of FNCH
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Volatile ride for Finch Therapeutics Group, Inc. stock price on Wednesday moving between $2.64 and $3.16
(Updated on Mar 27, 2024)

Hold candidate since Mar 25, 2024 Gain 7.19% PDF

The Finch Therapeutics Group, Inc. stock price gained 9.42% on the last trading day (Wednesday, 27th Mar 2024), rising from $2.65 to $2.89. During the last trading day the stock fluctuated 19.70% from a day low at $2.64 to a day high of $3.16. The price has been going up and down for this period, and there has been a 13.05% gain for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 974 more shares were traded than the day before. In total, 3 thousand shares were bought and sold for approximately $9.79 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -20.78% during the next 3 months and, with a 90% probability hold a price between $1.56 and $2.58 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

FNCH Signals & Forecast

The Finch Therapeutics Group, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $2.71 and $2.60. A breakdown below any of these levels will issue sell signals. Finch Therapeutics Group, Inc. has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. The very low volume increases the risk and reduces the other technical signals issued. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Monday, March 11, 2024, and so far it has fallen -15.34%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Finch Therapeutics Group, Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $2.72 and $2.69. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Finch Therapeutics Group, Inc. finds support just below today's level at $2.72. If this is broken, then the next support from accumulated volume will be at $2.69 and $2.50.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.520 between high and low, or 19.70%. For the last week, the stock has had daily average volatility of 7.62%.

Our recommended stop-loss: $2.73 (-5.84%) (This stock has high daily movements and this gives high risk. There is a sell signal from a pivot top found 12 days ago.)

Trading Expectations (FNCH) For The Upcoming Trading Day Of Thursday 28th

For the upcoming trading day on Thursday, 28th we expect Finch Therapeutics Group, Inc. to open at $2.90, and during the day (based on 14 day Average True Range), to move between $2.59 and $3.20, which gives a possible trading interval of +/-$0.307 (+/-10.61%) up or down from last closing price. If Finch Therapeutics Group, Inc. takes out the full calculated possible swing range there will be an estimated 21.21% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $2.72 (6.02%) than the resistance at $3.30 (13.89%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Finch Therapeutics Group, Inc. stock A Buy?

Finch Therapeutics Group, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: 0.486 Hold/Accumulate Unchanged

Predicted Opening Price for Finch Therapeutics Group, Inc. of Thursday, March 28, 2024

Fair opening price March 28, 2024 Current price
$2.90 ( 0.136%) $2.89

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for FNCH

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 3.42 18.10 %
R2 3.22 11.24 %
R1 3.10 7.00 %
Current price: 2.89
Support S1 2.70 -6.73 %
S2 2.58 -10.97 %
S3 2.38 -17.83 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 3.45 19.21 %
R2 3.42 18.11 %
R1 3.30 13.89 %
Current price 2.89
Support S1 2.72 -6.02%
S2 2.69 -7.05%
S3 2.50 -13.62%

FAQ

What is the symbol for Finch Therapeutics Group, Inc. Stock and on which exchange is it traded?
The symbol for Finch Therapeutics Group, Inc. is FNCH and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Finch Therapeutics Group, Inc. Stock?
Finch Therapeutics Group, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Finch Therapeutics Group, Inc. Stock?
Finch Therapeutics Group, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Finch Therapeutics Group, Inc. Stock.

What's the current price of Finch Therapeutics Group, Inc. Stock?
As of the end of day on the 2024-03-27, the price of an Finch Therapeutics Group, Inc. (FNCH) share was $2.89.

What is the 52-week high and low for Finch Therapeutics Group, Inc. Stock?
The 52-week high for Finch Therapeutics Group, Inc. Stock is $16.74 and the 52-week low is $0.260.

What is the market capitalization of Finch Therapeutics Group, Inc. Stock?
As of the 2024-03-27, the market capitalization of Finch Therapeutics Group, Inc. is 4.247M.

When is the next earnings date for Finch Therapeutics Group, Inc.?
The upcoming earnings date for Finch Therapeutics Group, Inc. is May 08, 2024.
Click to get the best stock tips daily for free!

About Finch Therapeutics Group, Inc.

Finch Therapeutics Group. Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutics company, develops a novel class of orally administered biological drugs in the United States. The company's lead candidate is CP101, an orally administered microbiome capsule that is in Phase 3 clinical trial for the treatment of patients with recurrent Clostridioides difficile infection, as well as for the treatment of chronic hepatitis B virus. It is also developing FIN-21... FNCH Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT